Tariff No 133/2022 for marketing
authorisations, annual fees and other licence fees for medicinal products and
other related products, collected by the Icelandic Medicines Agency, was
published in the Official Journal on 27 January 2022 and came into force on 2 February 2022.
The
Tariff has been adjusted to changed circumstances and thus some fees have been reduced
On the other hand the turnover threshold for discounts of annual fees has been raised.
The English
version of the tariff is not available yet but will be published as soon as it
becomes available.